• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number 06C15-25
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/05/2022
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed a false negative architect cmv igg result generated on the architect i2000sr processing module for a stored aliquot sample of a pregnant female patient.Sid (b)(6) from july 2022 was initially tested on (b)(6) 2022 and was found to be negative for cmv igg and cmv igm.A subsequent sample from the same patient was tested and was cmv igg positive.Retested the original sample on (b)(6) 2022 and it was cmv igg positive.No impact to patient management was reported.
 
Event Description
The customer observed a false negative architect cmv igg result generated on the architect i2000sr processing module for a stored aliquot sample of a pregnant female patient.Sid (b)(6),from (b)(6) 2022 was initially tested on (b)(6) 2022 and was found to be negative for cmv igg and cmv igm.A subsequent sample from the same patient was tested and was cmv igg positive.Retested the original sample on (b)(6)2022 and it was cmv igg positive.No impact to patient management was reported.Update: additional information provided on 20sep2023.The following detailed were provided: on (b)(6) 2022 sample initially tested sid s, (b)(6) (lot 40507fn00) was cmg igg positive on (b)(6) 2022 or (b)(6) 2022 testing of the booking sample sid s,(b)(6) (lot 40507fn00) was cmv igg negative on (b)(6) 2023 retested booking sample sid s, (b)(6) was cmv igg positive on (b)(6) 2022 another sample received with sid s,(b)(6) was cmv igg positive no impact to patient management was reported.
 
Manufacturer Narrative
Additional information in section a1 patient identifier, b3 date of the event, b5 a1 patient identifier completed information: sids (b)(6).The complaint investigation for falsely non-reactive architect cmv igg results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Return testing was not completed as returns were not available.A review of tracking and trending did not identify any trends for the complaint issue.The device history record review on lot 40507fn00 did not show any potential non-conformances, deviations, or non-conformances associated with the complaint issue.Labeling was reviewed and found to adequately address the issue.Based on the investigation, no systemic issue or deficiency of the architect cmv igg assay for lot number 40507fn00 was identified.All available patient information was included.Additional patient details are not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CMV IGG REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI  F91VY44
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
sligo F91VY 44
EI   F91VY44
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17769341
MDR Text Key323829161
Report Number3008344661-2023-00169
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K220949
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/25/2023
Device Catalogue Number06C15-25
Device Lot Number40507FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/13/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
Patient SexFemale
-
-